1 REPORT OVERVIEW |
1.1 Study Scope |
1.2 Market Analysis by Type |
| 1.2.1 Global Drug Repositioning Market Size Growth Rate by Type: 2020 VS 2027 |
| 1.2.2 Generic Drugs |
| 1.2.3 Clinical Trial Failed Drugs |
1.3 Market by Application |
| 1.3.1 Global Drug Repositioning Market Share by Application: 2020 VS 2027 |
| 1.3.2 Cardiovascular Diseases |
| 1.3.3 Mental Illness |
| 1.3.4 Cancer |
1.4 Study Objectives |
1.5 Years Considered |
2 GLOBAL GROWTH TRENDS |
2.1 Global Drug Repositioning Market Perspective (2016-2027) |
2.2 Drug Repositioning Growth Trends by Regions |
| 2.2.1 Drug Repositioning Market Size by Regions: 2016 VS 2020 VS 2027 |
| 2.2.2 Drug Repositioning Historic Market Size by Regions (2016-2020) |
| 2.2.3 Drug Repositioning Forecasted Market Size by Regions (2021-2027) |
| 2.2.4 China Drug Repositioning Market Share in Global Market 2016-2027 |
2.3 Industry Trends and Growth Strategy |
| 2.3.1 Market Top Trends |
| 2.3.2 Market Drivers |
| 2.3.3 Market Challenges |
| 2.3.4 Porter檚 Five Forces Analysis |
3 COMPETITION LANDSCAPE BY KEY PLAYERS |
3.1 Global Top Drug Repositioning Players by Market Size |
| 3.1.1 Global Top Drug Repositioning Players by Revenue (2019-2020) |
| 3.1.2 Global Drug Repositioning Revenue Market Share by Players (2019-2020) |
| 3.1.3 Players Covered: Ranking by Drug Repositioning Revenue |
| 3.1.4 Global Drug Repositioning by Company Type (Tier 1, Tier 2 and Tier 3) |
3.2 Global Drug Repositioning Market Concentration Ratio |
| 3.2.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI) |
| 3.2.2 Global Top 3 and Top 5 Companies by Drug Repositioning Revenue in 2019 |
3.3 Drug Repositioning Key Players Head office and Area Served |
3.4 Key Players Drug Repositioning Product Solution and Service |
| 全:文：http://www.qdlaimaiche.com/2/85/Global-and-China-Drug-Repositioning-Market-Analysis-and-Trends-Forecast-Report-2021-2027.html |
3.5 Founded Date of Drug Repositioning Manufacturer |
3.6 Mergers & Acquisitions, Expansion Plans |
4 Drug Repositioning BREAKDOWN DATA BY TYPE |
4.1 Global Drug Repositioning Historic Market Size by Type (2016-2020) |
4.2 Global Drug Repositioning Forecasted Market Size by Type (2021-2027) |
5 Drug Repositioning BREAKDOWN DATA BY APPLICATION |
5.1 Global Drug Repositioning Historic Market Size by Application (2016-2020) |
5.2 Global Drug Repositioning Forecasted Market Size by Application (2021-2027) |
6 NORTH AMERICA |
6.1 North America Drug Repositioning Market Size YoY Growth 2016-2027 |
6.2 Drug Repositioning Key Players in North America (2019-2020) |
6.3 North America Drug Repositioning Market Size by Type (2016-2020) |
6.4 North America Drug Repositioning Market Size by Application (2016-2020) |
7 EUROPE |
7.1 Europe Drug Repositioning Market Size YoY Growth 2016-2027 |
7.2 Drug Repositioning Key Players in Europe (2019-2020) |
7.3 Europe Drug Repositioning Market Size by Type (2016-2020) |
7.4 Europe Drug Repositioning Market Size by Application (2016-2020) |
7.5 Europe Drug Repositioning Market Size by Country |
| 7.5.1 Europe Drug Repositioning Market Size by Country (2016-2020) |
| 7.5.2 Europe Drug Repositioning Market Size by Country (2021-2027) |
| 7.5.3 Germany |
| 7.5.4 France |
| 7.5.5 U.K. |
| 7.5.6 Italy |
| 7.5.7 Russia |
8 JAPAN |
8.1 Japan Drug Repositioning Market Size YoY Growth 2016-2027 |
8.2 Drug Repositioning Key Players in Japan (2019-2020) |
8.3 Japan Drug Repositioning Market Size by Type (2016-2020) |
8.4 Japan Drug Repositioning Market Size by Application (2016-2020) |
9 CHINA |
9.1 China Drug Repositioning Market Size YoY Growth 2016-2027 |
9.2 Drug Repositioning Key Players in China (2019-2020) |
9.3 China Drug Repositioning Market Size by Type (2016-2020) |
9.4 China Drug Repositioning Market Size by Application (2016-2020) |
10 SOUTHEAST ASIA |
10.1 Southeast Asia Drug Repositioning Market Size YoY Growth 2016-2027 |
10.2 Drug Repositioning Key Players in Southeast Asia (2019-2020) |
10.3 Southeast Asia Drug Repositioning Market Size by Type (2016-2020) |
10.4 Southeast Asia Drug Repositioning Market Size by Application (2016-2020) |
11 INDIA |
11.1 India Drug Repositioning Market Size YoY Growth 2016-2027 |
11.2 Drug Repositioning Key Players in India (2019-2020) |
11.3 India Drug Repositioning Market Size by Type (2016-2020) |
11.4 India Drug Repositioning Market Size by Application (2016-2020) |
12 KEY PLAYERS PROFILES |
12.1 Company 1 |
| 12.1.1 Company 1 Company Details |
| 12.1.2 Company 1 Business Overview |
| 12.1.3 Company 1 Drug Repositioning Introduction |
| 12.1.4 Company 1 Revenue in Drug Repositioning Business (2019-2020) |
| 12.1.5 Company 1 Recent Developments |
12.2 Company 2 |
| 12.2.1 Company 2 Company Details |
| 12.2.2 Company 2 Business Overview |
| 12.2.3 Company 2 Drug Repositioning Introduction |
| 12.2.4 Company 2 Revenue in Drug Repositioning Business (2019-2020) |
| 12.2.5 Company 2 Recent Developments |
12.3 Company 3 |
| 12.3.1 Company 3 Company Details |
| 12.3.2 Company 3 Business Overview |
| 12.3.3 Company 3 Drug Repositioning Introduction |
| 12.3.4 Company 3 Revenue in Drug Repositioning Business (2019-2020) |
| 12.3.5 Company 3 Recent Developments |
12.4 Company 4 |
| 12.4.1 Company 4 Company Details |
| 12.4.2 Company 4 Business Overview |
| 12.4.3 Company 4 Drug Repositioning Introduction |
| 12.4.4 Company 4 Revenue in Drug Repositioning Business (2019-2020) |
| 12.4.5 Company 4 Recent Developments |
12.5 Company 5 |
| 全球和中國藥物重新定位市場分析及趨勢預測報告2021-2027 |
| 12.5.1 Company 5 Company Details |
| 12.5.2 Company 5 Business Overview |
| 12.5.3 Company 5 Drug Repositioning Introduction |
| 12.5.4 Company 5 Revenue in Drug Repositioning Business (2019-2020) |
| 12.5.5 Company 5 Recent Developments |
12.6 Company 6 |
| 12.6.1 Company 6 Company Details |
| 12.6.2 Company 6 Business Overview |
| 12.6.3 Company 6 Drug Repositioning Introduction |
| 12.6.4 Company 6 Revenue in Drug Repositioning Business (2019-2020) |
| 12.6.5 Company 6 Recent Developments |
12.7 Company 7 |
| 12.7.1 Company 7 Company Details |
| 12.7.2 Company 7 Business Overview |
| 12.7.3 Company 7 Drug Repositioning Introduction |
| 12.7.4 Company 7 Revenue in Drug Repositioning Business (2019-2020) |
| 12.7.5 Company 7 Recent Developments |
12.8 Company 8 |
| 12.8.1 Company 8 Company Details |
| 12.8.2 Company 8 Business Overview |
| 12.8.3 Company 8 Drug Repositioning Introduction |
| 12.8.4 Company 8 Revenue in Drug Repositioning Business (2019-2020) |
| 12.8.5 Company 8 Recent Developments |
12.9 Company 9 |
| 12.9.1 Company 9 Company Details |
| 12.9.2 Company 9 Business Overview |
| 12.9.3 Company 9 Drug Repositioning Introduction |
| 12.9.4 Company 9 Revenue in Drug Repositioning Business (2019-2020) |
| 12.9.5 Company 9 Recent Developments |
12.10 Company 10 |
| 12.10.1 Company 10 Company Details |
| 12.10.2 Company 10 Business Overview |
| 12.10.3 Company 10 Drug Repositioning Introduction |
| 12.10.4 Company 10 Revenue in Drug Repositioning Business (2019-2020) |
| 12.10.5 Company 10 Recent Developments |
12.11 Company 11 |
| 12.11.1 Company 11 Company Details |
| 12.11.2 Company 11 Business Overview |
| 12.11.3 Company 11 Drug Repositioning Introduction |
| 12.11.4 Company 11 Revenue in Drug Repositioning Business (2019-2020) |
| 12.11.5 Company 11 Recent Developments |
12.12 Company 12 |
| 12.12.1 Company 12 Company Details |
| 12.12.2 Company 12 Business Overview |
| 12.12.3 Company 12 Drug Repositioning Introduction |
| 12.12.4 Company 12 Revenue in Drug Repositioning Business (2019-2020) |
| 12.12.5 Company 12 Recent Developments |
12.13 Company 13 |
| 12.13.1 Company 13 Company Details |
| 12.13.2 Company 13 Business Overview |
12.14 Company 14 |
| 12.14.1 Company 14 Company Details |
| 12.14.2 Company 14 Business Overview |
12.15 Company 15 |
| 12.15.1 Company 15 Company Details |
| 12.15.2 Company 15 Business Overview |
12.16 Company 16 |
| 12.16.1 Company 16 Company Details |
| 12.16.2 Company 16 Business Overview |
12.17 Company 17 |
| 12.17.1 Company 17 Company Details |
| 12.17.2 Company 17 Business Overview |
12.18 Company 18 |
| 12.18.1 Company 18 Company Details |
| 12.18.2 Company 18 Business Overview |
12.19 Company 19 |
| 12.19.1 Company 19 Company Details |
| 12.19.2 Company 19 Business Overview |
13 ANALYST'S VIEWPOINTS/CONCLUSIONS |
14 APPENDIX |
14.1 Research Methodology |
| 14.1.1 Methodology/Research Approach |
| 全球和中國藥物重新定位市場分析及趨勢預測報告2021-2027 |
| 14.1.2 Data Source |
14.2 Disclaimer |
14.3 Author Details |
| List of Tables |
| Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million): 2020 VS 2027 |
| Table 2. Global Drug Repositioning Market Size Growth by Application (US$ Million): 2020 VS 2027 |
| Table 3. Global Drug Repositioning Market Size by Regions (US$ Million): 2020 VS 2027 |
| Table 4. Global Drug Repositioning Market Size by Regions (2016-2020) & (US$ Million) |
| Table 5. Global Drug Repositioning Market Share by Regions (2016-2020) |
| Table 6. Global Drug Repositioning Forecasted Market Size by Regions (2021-2027) & (US$ Million) |
| Table 7. Global Drug Repositioning Market Share by Regions (2021-2027) |
| Table 8. Market Top Trends |
| Table 9. Key Drivers: Impact Analysis |
| Table 10. Key Challenges |
| Table 11. Global Drug Repositioning Revenue by Players (2019-2020) & (US$ Million) |
| Table 12. Global Drug Repositioning Market Share by Players (2019-2020) |
| Table 13. Ranking of Global Top Drug Repositioning Manufacturers by Revenue (US$ Million) in 2019 |
| Table 14. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Repositioning as of 2020) |
| Table 15. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2019-2020) |
| Table 16. Key Players Headquarters and Area Served |
| Table 17. Key Players Drug Repositioning Product Solution and Service |
| Table 18. Founded Date of Drug Repositioning Manufacturer |
| Table 19. Mergers & Acquisitions, Expansion Plans |
| Table 20. Global Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 21. Global Drug Repositioning Revenue Market Share by Type (2016-2020) |
| Table 22. Global Drug Repositioning Forecasted Market Size by Type (2021-2027) & (US$ Million) |
| Table 23. Global Drug Repositioning Revenue Market Share by Type (2021-2027) |
| Table 24. Global Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 25. Global Drug Repositioning Revenue Market Share by Application (2016-2020) |
| Table 26. Global Drug Repositioning Forecasted Market Size by Application (2021-2027) & (US$ Million) |
| Table 27. Global Drug Repositioning Revenue Market Share by Application (2021-2027) |
| Table 28. North America Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million) |
| Table 29. North America Key Players Drug Repositioning Market Share (2019-2020) |
| Table 30. North America Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 31. North America Drug Repositioning Market Share by Type (2016-2020) |
| Table 32. North America Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 33. North America Drug Repositioning Market Share by Application (2016-2020) |
| Table 34. Europe Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million) |
| Table 35. Europe Key Players Drug Repositioning Market Share (2019-2020) |
| Table 36. Europe Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 37. Europe Drug Repositioning Market Share by Type (2016-2020) |
| Table 38. Europe Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 39. Europe Drug Repositioning Market Share by Application (2016-2020) |
| Table 40. Europe Drug Repositioning Market Size by Country (2016-2020) & (US$ Million) |
| Table 41. Europe Drug Repositioning Market Size by Country (2021-2027) & (US$ Million) |
| Table 42. Japan Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million) |
| Table 43. Japan Key Players Drug Repositioning Market Share (2019-2020) |
| Table 44. Japan Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 45. Japan Drug Repositioning Market Share by Type (2016-2020) |
| Table 46. Japan Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 47. Japan Drug Repositioning Market Share by Application (2016-2020) |
| Table 48. China Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million) |
| Table 49. China Key Players Drug Repositioning Market Share (2019-2020) |
| Table 50. China Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 51. China Drug Repositioning Market Share by Type (2016-2020) |
| Table 52. China Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 53. China Drug Repositioning Market Share by Application (2016-2020) |
| Table 54. Southeast Asia Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million) |
| Table 55. Southeast Asia Key Players Drug Repositioning Market Share (2019-2020) |
| Table 56. Southeast Asia Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 57. Southeast Asia Drug Repositioning Market Share by Type (2016-2020) |
| Table 58. Southeast Asia Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 59. Southeast Asia Drug Repositioning Market Share by Application (2016-2020) |
| Table 60. India Key Players Drug Repositioning Revenue (2019-2020) & (US$ Million) |
| Table 61. India Key Players Drug Repositioning Market Share (2019-2020) |
| Table 62. India Drug Repositioning Market Size by Type (2016-2020) & (US$ Million) |
| Table 63. India Drug Repositioning Market Share by Type (2016-2020) |
| Table 64. India Drug Repositioning Market Size by Application (2016-2020) & (US$ Million) |
| Table 65. India Drug Repositioning Market Share by Application (2016-2020) |
| Table 66. Company 1 Company Details |
| Table 67. Company 1 Business Overview |
| Table 68. Company 1 Drug Repositioning Product |
| quánqiú hé zhōngguó yàowù chóngxīn dìngwèi shìchǎng fēnxī jí qūshì yùcè bàogào 2021-2027 |
| Table 69. Company 1 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 70. Company 1 Recent Developments |
| Table 71. Company 2 Company Details |
| Table 72. Company 2 Business Overview |
| Table 73. Company 2 Drug Repositioning Product |
| Table 74. Company 2 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 75. Company 2 Recent Developments |
| Table 76. Company 3 Company Details |
| Table 77. Company 3 Business Overview |
| Table 78. Company 3 Drug Repositioning Product |
| Table 79. Company 3 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 80. Company 3 Recent Developments |
| Table 81. Company 4 Company Details |
| Table 82. Company 4 Business Overview |
| Table 83. Company 4 Drug Repositioning Product |
| Table 84. Company 4 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 85. Company 4 Recent Developments |
| Table 86. Company 5 Company Details |
| Table 87. Company 5 Business Overview |
| Table 88. Company 5 Drug Repositioning Product |
| Table 89. Company 5 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 90. Company 5 Recent Developments |
| Table 91. Company 6 Company Details |
| Table 92. Company 6 Business Overview |
| Table 93. Company 6 Drug Repositioning Product |
| Table 94. Company 6 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 95. Company 6 Recent Developments |
| Table 96. Company 7 Company Details |
| Table 97. Company 7 Business Overview |
| Table 98. Company 7 Drug Repositioning Product |
| Table 99. Company 7 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 100. Company 7 Recent Developments |
| Table 101. Company 8 Company Details |
| Table 102. Company 8 Business Overview |
| Table 103. Company 8 Drug Repositioning Product |
| Table 104. Company 8 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 105. Company 8 Recent Developments |
| Table 106. Company 9 Company Details |
| Table 107. Company 9 Business Overview |
| Table 108. Company 9 Drug Repositioning Product |
| Table 109. Company 9 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 110. Company 9 Recent Developments |
| Table 111. Company 10 Company Details |
| Table 112. Company 10 Business Overview |
| Table 113. Company 10 Drug Repositioning Product |
| Table 114. Company 10 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 115. Company 10 Recent Developments |
| Table 116. Company 11 Company Details |
| Table 117. Company 11 Business Overview |
| Table 118. Company 11 Drug Repositioning Product |
| Table 119. Company 11 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 120. Company 11 Recent Developments |
| Table 121. Company 12 Company Details |
| Table 122. Company 12 Business Overview |
| Table 123. Company 12 Drug Repositioning Product |
| Table 124. Company 12 Revenue in Drug Repositioning Business (2019-2020) & (US$ Million) |
| Table 125. Company 12 Recent Developments |
| Table 126. Company 13 Company Details |
| Table 127. Company 13 Business Overview |
| Table 128. Company 14 Company Details |
| Table 129. Company 14 Business Overview |
| Table 130. Company 15 Company Details |
| Table 131. Company 15 Business Overview |
| Table 132. Company 16 Company Details |
| Table 133. Company 16 Business Overview |
| Table 134. Company 17 Company Details |
| Table 135. Company 17 Business Overview |
| Table 136. Company 18 Company Details |
| Table 137. Company 18 Business Overview |
| Table 138. Company 19 Company Details |
| Table 139. Company 19 Business Overview |
| Table 140. Research Programs/Design for This Report |
| 世界と中國の薬物の再配置市場分析とトレンド予測レポート2021-2027 |
| Table 141. Key Data Information from Secondary Sources |
| Table 142. Key Data Information from Primary Sources |
| List of Figures |
| Figure 1. Global Drug Repositioning Market Share by Type: 2020 |
| Figure 2. Global Drug Repositioning Market Share by Type: 2027 |
| Figure 3. Generic Drugs Features |
| Figure 4. Global Drug Repositioning Market Share by Application: 2020 |
| Figure 5. Global Drug Repositioning Market Share by Application: 2027 |
| Figure 6. Cardiovascular Diseases Case Studies |
| Figure 7. Mental Illness Case Studies |
| Figure 8. Cancer Case Studies |
| Figure 9. Drug Repositioning Report Years Considered |
| Figure 10. Global Drug Repositioning Market Size, (US$ Million), 2016 VS 2020 VS 2027 |
| Figure 11. Global Drug Repositioning Market Size YoY Growth 2016-2027 (US$ Million) |
| Figure 12. Global Drug Repositioning Market Share by Regions: 2020 |
| Figure 13. Global Drug Repositioning Market Share by Regions: 2027 |
| Figure 14. Global Drug Repositioning Market Share by Regions (2021-2027) |
| Figure 15. China Drug Repositioning Market Share in Global Market 2016-2027 |
| Figure 16. Porter's Five Forces Analysis |
| Figure 17. Global Drug Repositioning Market Share by Players in 2019 |
| Figure 18. The Top 5 Players Market Share by Drug Repositioning Revenue in 2019 |
| Figure 19. The Top 3 Players Market Share by Drug Repositioning Revenue in 2019 |
| Figure 20. North America Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 21. Europe Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 22. Europe Drug Repositioning Market Share by Country (2016-2027) |
| Figure 23. Germany Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 24. France Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 25. U.K. Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 26. Italy Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 27. Russia Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 28. Japan Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 29. China Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 30. Southeast Asia Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 31. India Drug Repositioning Market Size YoY Growth (2016-2027) & (US$ Million) |
| Figure 32. Bottom-up and Top-down Approaches for This Report |
| Figure 33. Data Triangulation |
| Figure 34. Key Executives Interviewed |
…
如需購買《Global and China Drug Repositioning Market Analysis and Trends Forecast Report 2021-2027》，編號：3056852
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號